Loading stock data…
AMST
$1.29+0.04 (+3.20%)
Pre-Market$1.25-0.04 (-2.96%)· Last close Jun 9
Amesite Inc., a technology company, engages in the marketing and development of B2C and B2B AI-driven solutions in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Amesite Inc. in the Technology sector is trading at $1.28 with a market capitalization of $8M. The stock is currently near its 52-week low of $0.77, remaining 42.1% below its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: MACD remains below its signal line. The Whystock Score of 60/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Long-term trend bearish (price vs 200-day SMA)
Oversold momentum (RSI 30) — potential for technical mean-reversion
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $83,332↓ | $108,050↑ | $94,296↑ | $55,759↑ | $30,690 |
| Gross Profit | — | — | — | — | — |
| Operating Income | -$684,072↑ | -$745,253↓ | -$662,124↑ | -$857,678↓ | -$687,722 |
| Net Income | -$678,061↑ | -$732,548↓ | -$642,266↑ | -$923,986↓ | -$663,418 |
Peer Comparison
AAPLMSFTGOOGL
Fundamentals
Amesite Inc., a technology company, engages in the marketing and development of B2C and B2B AI-driven solutions in the United States. Its products include Amesite Engage, that leverages proprietary AI infrastructure, offering cutting-edge application...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$7.55M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
0.94
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-228.57%
Volume
Today's trading volume
140,256
Recent News
Amesite Stock Soars 150% on New Enterprise Deal. What to Know.
Amesite shares soar on a major healthcare AI contract. But there are ample reasons to avoid chasing the momentum in AMST shares today.
Amesite Rips 250% On Its Largest AI Healthcare Deployment
Amesite secured a new enterprise customer representing an approximately 2,700-patient census for NurseMagic AI documentation.
Amesite shares skyrocket after landing largest enterprise client to date (AMST)
NurseMagic platform selected for large-scale healthcare deploymentAmesite Inc. (NASDAQ:AMST) shares soared 190% in premarket trading Tuesday after the company announced it had secured its largest enterprise customer so far, covering approximately 2,700 patients.
Amesite reports $6M concurrent registered direct offering, private placement
Amesite (AMST) announced that it has entered into definitive agreements for the purchase and sale of 696,866 shares of its common stock, at a purchase price of $1.435 per share in a registered direct offering priced at-the-market under Nasdaq rules. In addition, the company has agreed to issue to the investor unregistered Series A-1 warrants to purchase up to 696,866 shares of common stock and unregistered Series A-2 warrants to purchase up to 696,866 shares of common stock. The warrants will ha
Amesite introduces AI-native EMR system, NurseMagic EMR
The system extends the NurseMagic platform from a point-of-care solution to an enterprise-level infrastructure.